NCT04373616View on ClinicalTrials.gov

A Study of ACI-24 in Adults With Down Syndrome

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 31, 2021

Primary Completion Date

April 30, 2024

Study Completion Date

October 31, 2024

Conditions

Down Syndrome

Interventions

BIOLOGICAL

ACI-24

injections

BIOLOGICAL

Placebo

injections

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AC Immune SA

INDUSTRY